2.49
前日終値:
$2.58
開ける:
$2.58
24時間の取引高:
555.77K
Relative Volume:
1.10
時価総額:
$197.02M
収益:
$130.42M
当期純損益:
$18.64M
株価収益率:
11.41
EPS:
0.2182
ネットキャッシュフロー:
$4.05M
1週間 パフォーマンス:
-7.43%
1か月 パフォーマンス:
-17.00%
6か月 パフォーマンス:
-47.36%
1年 パフォーマンス:
-66.44%
Niagen Bioscience Inc Stock (NAGE) Company Profile
名前
Niagen Bioscience Inc
電話
310-388-6706
住所
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs JBS, KHC, GIS, SJM, MKC.V
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NAGE
Niagen Bioscience Inc
|
2.49 | 197.02M | 130.42M | 18.64M | 4.05M | 0.2182 |
|
JBS
Jbs Nv
|
13.03 | 42.87B | 88.25B | 1.91B | -681.64M | 1.6761 |
|
KHC
Kraft Heinz Co
|
23.68 | 28.08B | 24.99B | -5.76B | 3.95B | -4.863 |
|
GIS
General Mills Inc
|
33.13 | 17.71B | 18.42B | -85.30M | 1.63B | -0.1894 |
|
SJM
J M Smucker Co
|
127.43 | 13.61B | 9.05B | -138.70M | 1.16B | -1.307 |
|
MKC.V
McCormick & Company, Incorporated Voting CS
|
46.88 | 12.61B | 0 | 0 | 0 | 0.00 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | 開始されました | Canaccord Genuity | Buy |
| 2022-08-16 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-08-11 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2019-10-16 | 開始されました | Oppenheimer | Outperform |
| 2019-02-14 | 開始されました | B. Riley FBR | Buy |
| 2017-11-27 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-03 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Niagen Bioscience Inc (NAGE) 最新ニュース
Niagen Bioscience to present at Canaccord Genuity’s 46th Annual Growth Conference - scanx.trade
Niagen Bioscience to Present at Canaccord Genuity’s Well Summit - Business Wire
Niagen Bioscience to Present at Longevity Investors Conference - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of "Buy" by Brokerages - marketbeat.com
NAGE Price History for Niagen Bioscience Stock - Barchart.com
Niagen Bioscience at Midwest IDEAS: cash-rich growth and drug bets - Investing.com India
Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit - Yahoo Finance
Niagen Bioscience CFO presents at Nasdaq X LD Micro SF summit - scanx.trade
Niagen (NAGE) Results at a Glance: Profit Per Share Falls Below Its Benchmark in Latest Trading; Market Response - vinanet.vn
Niagen Bioscience stock gains GNC, Sam’s Club distribution, Canaccord reiterates buy - Investing.com
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - Sahm
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - simplywall.st
Niagen Bioscience Leads The Way With 2 Promising Penny Stocks - simplywall.st
Supplement Retail Expansions - Trend Hunter
Supplement Retail Expansions - Trend Hunter
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores - Investing.com
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com India
Niagen Bioscience expands Tru Niagen to GNC, Sam’s Club stores By Investing.com - Investing.com UK
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - New Castle News
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - Nasdaq
Tieton Capital Management LLC Purchases New Position in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club - Yahoo Finance
Niagen (NAGE) Results at a Glance: EPS Does Not Reach the Reported Estimate for the Current Session; Price Reaction: The Stock Gains 4.71%Earnings Stability Report - vinanet.vn
Niagen (NAGE): Closes 0.33% Higher at $3.05 on the Day; Range and Risk: the Supplied Trading Band Runs From $2.90 to $3.20 on the DayAndrews Pitchfork - vinanet.vn
Niagen Bioscience (NAGE) Eases to $3.02 as Support Level Comes into FocusLong Term Entry Picks - Vinanet
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerArms Index - vinanet.vn
Niagen Bioscience (NAGE) Holds Above $2.9 Support as Shares Drift LowerShort Setup Alerts - siam.in
Niagen Bioscience to Present at Midwest IDEAS Investor Conference - Bitget
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India
Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com Canada
Niagen Bioscience at canaccord growth conference: cash, science and growth - Investing.com
Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative? - finance.yahoo.com
HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof - simplywall.st
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine
Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - kalkine.ca
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com South Africa
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com
HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat
Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com UK
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance
NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView
Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com
Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat
Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance
Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st
Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Niagen Bioscience Inc (NAGE) 財務データ
収益
当期純利益
現金流量
EPS
Niagen Bioscience Inc (NAGE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.81 |
4,465 |
30,406 |
7,372 |
| Pamir Ozan | Chief Financial Officer |
Nov 14 '25 |
Buy |
6.85 |
2,220 |
15,210 |
2,220 |
大文字化:
|
ボリューム (24 時間):